Article

Prices versus costs of production for molnupiravir as a COVID-19 treatment

2021-12-15

Abstract excerpt

<h4>Background: </h4> Molnupiravir has been recently approved in the United Kingdom for the treatment of COVID-19 for showing promising survival benefits in clinical trials. This analysis will estimate and compare potential generic minimum costs of molnupiravir as well as observe countries eligible for pricing discounts as agreed by Merck and The Medicines Patent Pool (MPP). Methods Drug prices were searched for...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f2f2fa0d-0a0f-5a44-a1e5-1839722d10c2
DOI: 10.21203/rs.3.rs-1169509/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prices versus costs of production for molnupiravir as a COVID-19 treatmentDOI 10.21203/rs.3.rs-1169509/v1Read

Estimated global cost of treating COVID-19, HIV, Hepatitis B and Hepatitis C with approved effective oral medicationsSemantic proximity Read

Shining a light in the black box of orphan drug pricingSemantic proximity Read

Guiding the willingness to pay for repurposed tiratricol in the treatment of Allan-Herndon-Dudley syndrome using a cost-based-plus pricing frameworkSemantic proximity Read

Methodological Challenges in Dutch HTA of Non-Oncological Orphan Drugs: A Retrospective Analysis and Price Comparison Using different Pricing ModelsSemantic proximity Read

The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?Semantic proximity Read

Drug Pricing Evolution in Hepatitis C.Semantic proximity Read

Differences in the cost of manufacturing pharmaceuticals in India for differently regulated markets: A comparative analysisSemantic proximity Read

How Low Could Semaglutide Prices Fall? An Analysis of Production Cost and Implications for Global Access Ahead of Patent ExpirySemantic proximity Read

Are quality medicines affordable? Evidence from a large survey of medicine price and quality in IndonesiaSemantic proximity Read

Estimated Costs of Production Compared with National Prices, for Drugs to Treat Clinical ObesitySemantic proximity Read

Cost-effectiveness analysis of COVID-19 booster doses and oral antivirals in the Indo-PacificSemantic proximity Read

Evolving Health Policies and Pricing Dynamics in U.S. Multiple Sclerosis Therapies: A Longitudinal Analysis with Policy ImplicationsSemantic proximity Read